Last update 06 Sep 2025

CYT013-IL1bQb

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms
Anti-interleukin 1 beta vaccine, CYT 013 IL1BQB, CYT013-IL1BQB
Target
IL-1β
Action
modulators
Mechanism
IL-1β modulators(Interleukin-1 beta modulators)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Diabetes Mellitus, Type 2
Originator Organization
Kuros Biosciences Ltd.Kuros Biosciences Ltd.
Active Organization-
Inactive Organization
Kuros Biosciences Ltd.Kuros Biosciences Ltd.Cytos Biotechnology AG
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with CYT013-IL1bQb
NCT00924105
/ CompletedPhase 1
A Two-Stage Randomized Placebo-controlled Ascending Dose Phase I/ IIa Study to Evaluate Safety, Tolerability, Pharmacodynamic Effects and Preliminary Efficacy of an Anti-Interleukin 1 Beta Vaccine (CYT013-IL1bQb) in Patients With Type 2 Diabetes Mellitus
EUCTR2008-007012-15-DE
/ Not yet recruitingNot Applicable
A Two-Stage Randomized Placebo-controlled Ascending Dose Phase I/ IIa Study to Evaluate Safety, Tolerability, Pharmacodynamic Effects and Preliminary Efficacy of an Anti-Interleukin 1 beta Vaccine (CYT013-IL1bQb) in Patients with Type 2 Diabetes Mellitus.
100 Clinical Results associated with CYT013-IL1bQb
Login to view more data
100 Translational Medicine associated with CYT013-IL1bQb
Login to view more data
100 Patents (Medical) associated with CYT013-IL1bQb
Login to view more data
100 Deals associated with CYT013-IL1bQb
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 2-
Kuros Biosciences Ltd.Kuros Biosciences Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free